Devices › Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction
Device brand name · Medtronic infuse
Medtronic Infuse Bone Graft Or Rhbmp2: medical device reports filed with FDA
483 reports name it, 2012–2013. Manufacturer given most often on reports: Medtronic. Product code NEK.
- 483
- device reports naming the brand
- 0% of all MAUDE reports · about 35 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 0%
- classified as malfunction
- 0.7% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 483 reports that name the brand "Medtronic Infuse Bone Graft Or Rhbmp2" (medtronic infuse), received between October 2012 and November 2013; the manufacturer given most often on reports is Medtronic. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (94.8%) and other (0.4%); across all filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction reports (product code NEK) death is recorded in 0.3% and malfunction in 0.7%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (86.7%), device operates differently than expected (6.8%) and patient-device incompatibility (0.8%). The patient problems coded most often are pain, injury and emotional changes. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Medtronic Infuse Bone Graft Or Rhbmp2 was received in the five years to August 2026; the latest was received in November 2013.
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 13,040 reports carrying product code NEK. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 419 | 86.7% | 7.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 33 | 6.8% | 0.7% |
| Patient-device incompatibilitythe device did not suit the patient | 4 | 0.8% | 0.3% |
| Improper or incorrect procedure or method | 1 | 0.2% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 471 | 97.5% |
| Injurya physical injury | 128 | 26.5% |
| Emotional changes | 117 | 24.2% |
| Anxietyanxiety | 101 | 20.9% |
| Disability | 86 | 17.8% |
| Nerve damage | 65 | 13.5% |
| Limited mobility of the implanted joint | 39 | 8.1% |
| Ambulation or postural difficulties | 23 | 4.8% |
| Reactiona reaction, type not specified | 20 | 4.1% |
| Cognitive changes | 15 | 3.1% |
| Discomfortdiscomfort | 9 | 1.9% |
| Loss of range of motion | 8 | 1.7% |
| Cancer | 7 | 1.4% |
| Distress | 5 | 1% |
| Host-tissue reaction | 5 | 1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Medtronic Infuse Bone Graft Or Rhbmp2 | Product code NEK | All MAUDE reports |
|---|---|---|---|
| Reports | 483 | 13,040 | 26,136,888 |
| Share of that pool | — | 3.7% | 0% |
| Classified as death, per 1,000 reports | 0 | 3 | 9 |
| Classified as injury | 94.8% | 98.5% | 36.2% |
| Classified as malfunction | 0% | 0.7% | 62.3% |
| Filed by the manufacturer | 0% | 94.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NEK
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Infuse Bone Graft | 12,081 | 36 | 0.3% |
| Verte-Stack Spinal System | 212 | 0 | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Medtronic Infuse Bone Graft Or Rhbmp2 reports
How many FDA reports name Medtronic Infuse Bone Graft Or Rhbmp2?
483 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (94.8%) and other (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (86.7%), device operates differently than expected (6.8%), patient-device incompatibility (0.8%) and improper or incorrect procedure or method (0.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
voluntary reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Medtronic Infuse Bone Graft Or Rhbmp2 was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.